Old Parkinson’s drug helps teens with type 1 diabetes
The Parkinson’s disease drug bromocriptine lowered blood pressure and reduced aortic stiffness in young people with type 1 diabetes.
Scientists uncover key to future hepatitis C vaccine
While treatments are available for HCV-related infections, they are expensive, hard to access, and do not protect against reinfection.
FDA approves US’s first fecal transplant therapy
The FDA has approved Rebyota, a slurry used during fecal transplant therapy to treat recurrent C. difficile infections.
How flu got milder since 1918 pandemic
The risk of death from influenza has declined over time, but globally, hundreds of thousands of people still die from the disease each year.
Newly discovered gut bacteria may be a culprit behind rheumatoid arthritis
This bacteria is found only in the intestines of people with rheumatoid arthritis, and not in the intestines of healthy people.
How to fight Covid with light
Some wavelengths of light in a range called far-UVC kill microbes in experiments and appear to be harmless to people.
The (robotic) doctor will see you now
Study finds patients are receptive to interacting with robots designed to evaluate symptoms in a contact-free way.
New brain cancer vaccine completes clinical trial
Northwest Biotherapeutics reports that its new brain cancer vaccine can extend glioblastoma patients’ lives by months or even years.
New chemo pump for brain tumors could avoid side effects
A fully implantable chemo pump could help extend the lives of people with deadly brain tumors while minimizing treatment side effects.
UK study suggests single dose of monkeypox vaccine is 78% effective
A new analysis by the UK Health Security Agency has determined that one shot of a monkeypox vaccine is 78% effective at preventing infection.
$3.5 million treatment for hemophilia wins FDA approval
The FDA has approved biotech company CSL Behring's Hemgenix, a hemophilia B treatment that costs $3.5 million per dose.
New CRISPR cancer treatment tested in humans for first time
A new personalized CRISPR cancer treatment modifies the immune system's T cells to help them recognize a specific patient's tumor cells.
Good and bad memories are stored in different neurons, study finds
Positive and negative memories are stored in different parts of the brain, raising the possibility of therapeutic memory manipulation.
Injectable gel repairs severe spinal cord injuries and enables mice to walk
An injectable gel that prevents scar formation and stimulates regeneration successfully repaired severe spinal cord injuries in mice.
Study finds mindfulness as effective as medication for anxiety
An intensive form of mindfulness was found as effective as Lexapro in treating anxiety in adults in the first head-to-head comparative study.
Moderna to develop mRNA vaccines for Ebola
Moderna is reportedly nearing a deal with the DoD to develop mRNA vaccines for biological threats like Ebola
Cheap blood pressure med could help treat alcoholism
Spironolactone, a cheap medication used to treat high blood pressure, might also be able to help people overcome alcohol use disorder.
Brain implant translates neural activity into letters, letting a paralyzed man “speak”
A new device allowed a paralyzed patient to "speak," spelling out full sentences in real-time with an error rate of about 8%.
Old herpes drug helps kill deadly superbug
The anti-herpes drug edoxudine can weaken the deadly superbug K-pneumoniae, potentially offering a new weapon against antibiotic resistance.
Doctors may not be ready for blood tests that screen for multiple cancers at once
MCED tests are different from existing ones because they are trying to detect early-stage cancer, when there aren’t that many tumor cells.
African researchers push for a human challenge trial to fight TB
Tuberculosis kills over a million people a year. Researchers in Malawi are pushing for a clinical trial that may help change that.
A new therapy sends lupus into remission
Five patients in Germany had their lupus wiped out by CAR T-cell therapy.
Engineered bacteria may fight this brain-damaging genetic disorder
A possible phenylketonuria therapy using engineered bacteria has shown positive results in a small phase 2 trial.
A malaria-fighting antibody has passed phase 2 trials
An antibody designed to prevent malaria infection has proven effective in phase 2 trials in Mali.
UK trials world’s first lab-grown blood transfusions
UK researchers have launched the world’s first trial in which lab-grown blood cells are being transfused into another person.
New mRNA vaccine for flu and COVID-19 enters human trials 
Pfizer and BioNTech's new mRNA vaccine designed to protect against COVID-19 and the flu has entered human trials.
New study will put the leading theory about Alzheimer’s to the test
Washington University in St. Louis is embarking on a drug trial that may also put the amyloid hypothesis to its ultimate test.
Organ regeneration could overcome liver failure, without a transplant
Patients wait from 30 days to over five years to receive a liver transplant in the U.S. What if the liver could regenerate itself instead?
New exercise study could find drugs that mimic working out 
MIT and Harvard researchers mapped out many of the cells, genes, and cellular pathways that are modified by exercise or high-fat diet.
Pfizer’s RSV vaccine for pregnant women protects newborns
Pfizer plans to begin the regulatory approval process by the end of the year.
AI-discovered drug for ALS enters human trials in just four years
Verge Genomics has begun a trial of their AI-found ALS drug candidate, one of the first tests for this new method of drug discovery.
Understanding cancer’s “dark matter”
Researchers have discovered that cancer’s epigenome — changes to how genes are expressed that aren’t mutations — may play a key role in its behavior.
FDA approves first-of-its-kind blood cancer treatment 
The FDA has approved Johnson & Johnson’s Tecvayli, a new blood cancer treatment for people with relapsed or refractory multiple myeloma.
Australian researchers have manufactured a living blood vessel 
A blood vessel isn’t just a simple tube. Researchers at the University of Sydney have developed an implant capable of mimicking its complexities.
Flu and RSV can fuse into a new kind of virus
In a new discovery, researchers at the University of Glasgow have observed hybrid viruses capable of infecting lung cells in the lab.
New smart contact lens monitors for glaucoma 24/7
Purdue researchers have created a smart, soft contact lens that can test for eye pressure, a key indicator of glaucoma, 24 hours a day.
Experimental “FLASH” cancer treatment aces first human trial
The first-in-human trial of FLASH radiotherapy found the experimental cancer treatment to be safe and effective.
Withdrawal symptoms from antidepressants can last over a year
A scientific review found that withdrawal symptoms from antidepressants and antipsychotics can last for over a year.
Merck pays Moderna $250m for personalized cancer vaccine
Pharma giant Merck has paid Moderna $250 million to co-develop and commercialize its promising mRNA-based personalized cancer vaccine.
Scientists discover slug that can decapitate itself, grow new body 
Scientists observed two species of sea slug that were able to self-decapitate, survive for weeks without organs, and regenerate new bodies.
Deep brain stimulation can be life-altering for OCD sufferers when other treatment options fall short 
Deep brain stimulation relies on thin electrodes implanted deep in the brain that deliver electrical currents. Could it treat OCD?
New vaccine prevents 94% of severe RSV cases 
UK drugmaker GSK’s RSV vaccine was nearly 95% effective at preventing severe infection in a phase 3 trial of older adults.
As Ebola reaches Ugandan capital, vaccines race to catch up 
Caused by the Sudan strain of Ebola, current vaccines and therapies approved for Ebola won’t work in Uganda. But these might.
UK scientists solve a decades-long blood mystery
Researchers have discovered a new blood group which may have been behind the tragic loss of two babies.
Male birth control options are in development, but a number of barriers still stand in the way
A survey of over 9,000 men in nine countries found that over 55% would be willing to use a new method of male birth control.
First-of-its-kind surgery may have helped reverse baby’s paralysis 
The first recipient of a groundbreaking spina bifida treatment is now one year old and showing no signs of leg paralysis.
It may be possible to treat inherited blindness, even in adults
A new mouse study suggests that synthetic retinoids may be able to help restore vision in adults with Leber congenital amaurosis.
Cambridge researchers have discovered how cancer spreads
New research out of the University of Cambridge may have discovered a mechanism behind metastasis.
New test catches deadly bloodstream infections much faster
Bloodstream infections have a high mortality rate. But a new test to catch them faster could lead to more saved lives.
A newly discovered class of RNA can fight off multiple viruses, including flu and SARS-CoV-2
Harvard-affiliated researchers have discovered a form of double-stranded RNA which may be a potent antiviral.
Tiny robots completely clear out deadly pneumonia infection in mice
Researchers have created microscopic robots capable of clearing pneumonia from the lungs of mice.
A modified herpes virus completely wiped out a terminal cancer
In a small phase 1 trial of a herpes-based cancer therapy, one patient had their tumors completely eliminated.
Scientists claim “never before” seen results in ALS clinical trial 
The ability of tofersen, a gene-based treatment for ALS, to improve symptoms is being hailed as a “treatment milestone.”
New Alzheimer’s drug slows mental decline by 27% in clinical trial
Eisai and Biogen are reporting that their new Alzheimer’s antibody slowed cognitive decline by 27% in a global trial.
Shape-shifting DNA is helping researchers decode the human brain
Researcher Nako Nakatsuka has turned to DNA to tackle an important challenge: how do we measure chemicals in the brain?
What’s causing the alarming rise in cancer for adults under 50
A new review finds that 14 different cancers, including eight related to the digestive system, are increasing in people under age 50.
Creatine, a popular exercise supplement, might help treat depression
Creatine shows promise as a treatment for depression, boosting the effects of SSRIs and potentially working as a standalone medication.
Axolotls can regenerate their brains 
Axolotls are a model organism researchers use to study a variety of topics in biology because of their regenerative abilities.
New treatment “starves” aggressive brain tumors in mice
A treatment that “starved” aggressive glioblastoma tumors in the brains of mice suggests a way to finally fight the deadly cancer in humans.
Meth addiction treatments are finally on the horizon
New antibody and drug therapies may soon help treat meth patients, who currently have no pharmacological interventions.
Blood test can find dozens of types of cancer, with few false positives
Grail’s Galleri multi-cancer blood test found multiple cancers in a study of over 6,000 patients.
ARPA-H: High-risk, high-reward health research is the mandate of new, billion-dollar US agency 
A new multibillion-dollar federal agency was created with a goal of supporting “the next generation of moonshots for health.”
Long COVID: Self-targeted immune attacks may lurk behind it
Researchers are working to get a more complete understanding of the cells and antibodies behind long COVID.
How NASA is planning to prevent a Martian plague 
When Mars samples arrive, they may carry more than knowledge. To offset the chance of a Martian pandemic, NASA is learning to contain a Red Planet plague.
Breakthrough drug could save hundreds of thousands of children’s lives
A booster dose of the University of Oxford’s malaria vaccine demonstrated up to 80% efficacy in children over a year of follow-up.
Newly discovered antibody neutralizes all variants of the coronavirus 
Using modified mouse models originally designed for HIV, researchers have discovered an antibody that stops all known strains of COVID-19.
At long last, we might have an HIV vaccine 
Due to HIV-1's extraordinary diversity, a vaccine needs to induce antibodies that can target many different strains.
First-of-its-kind trial will attempt to grow mini livers in people
A new treatment that could turn a single donor liver into “mini livers” capable of saving 75 or more lives is heading into human trials.
Woman with rare gene mutations feels no pain, anxiety
A woman in Scotland was found to feel virtually no pain and report zero trace of any anxiety or depression.
Insulin pills could end the need for painful injections
Insulin pills designed to be dissolved in the mouth appear to overcome a major hurdle holding back the development of oral insulin.
5 drugs that changed the world (and what went wrong)
Anesthesia, penicillin, antibiotics, diazepam, and the birth control pill have all radically changed our lives.
“Synthetic biomarkers” could catch your cancer in the future 
When the body’s own biomarkers aren’t enough, researchers have begun creating their own to help fight cancer.
An international team sets out to cure genetic heart diseases with one shot
Researchers from the UK, US, and Singapore are beginning work on a genetic heart cure they hope to begin clinically testing within five years.
Researchers may have created a universal coronavirus vaccine
All currently licensed COVID-19 vaccines target the spike protein’s S1 region, which is prone to mutations. We need a universal vaccine.
Pfizer’s RSV vaccine is 86% effective at preventing severe illness
According to a huge phase 3 trial, Pfizer’s RSV vaccine is nearly 86% effective at preventing severe illness in older adults.
Scientists convert kidney to universal “O” blood type
Kidneys still need to be tissue matched, but by converting them to type O, more will be available for transplant.
New epilepsy treatment could stop seizures in their tracks
A new epilepsy treatment that's delivered as a nasal spray may be able to prevent seizures or even interrupt them.
A sepsis-catching AI has proven effective in hospitals
A new AI for spotting sepsis, which accounts for ⅓ of hospital deaths, was found to be effective in a large trial.
What smart toilet seats reveal about digital health’s evolution 
Digital health is attracting record levels of investment in products such as smart toilet seats, which can help millions get access to care.
First personalized CRISPR therapy approved for trial
The FDA has approved a trial for the first personalized CRISPR therapy, which was developed to treat Duchenne muscular dystrophy.
Light pulses can stop dangerous food poisoning like Salmonella
A team at Penn State has developed a pulsed light technique capable of killing common food poisoning pathogens.
Synthetic cartilage is now stronger than the real stuff 
Using a heating process, Duke researchers have created a synthetic cartilage hydrogel that can outperform the real thing.
New kind of schizophrenia drug aces human trial
KarXT, a new schizophrenia treatment that addresses a wider range of symptoms than existing meds, has aced a phase 3 trial.
Viruses may one day treat inflammatory bowel disease
Researchers have created a cocktail of viruses that may be able to treat inflammatory bowel diseases like Crohn’s.
Nanoparticle sensor can distinguish between viral and bacterial pneumonia
MIT researchers have designed a sensor that can distinguish between viral and bacterial pneumonia infections.
Yale study finds low levels of a hormone may predict long COVID 
Yale and Icahn School of Medicine researchers may have found biomarkers for identifying long COVID.
Only human Lyme vaccine in development enters phase 3 trial
Pfizer and French biotech Valneva have announced a phase 3 clinical trial testing the human Lyme vaccine.
Half of all vaccines are wasted. A gel could save them.
A new hydrogel that wraps around heat-sensitive molecules could help prevent vaccine waste by keeping them viable at higher temperatures.
What ever happened to the first cryogenically frozen humans? 
For decades, people have arranged to freeze their bodies after death, dreaming of resurrection by advanced future medicine.
A new drug could repair stroke damage to memory and movement 
A new drug can repair stroke damage in mice, improving memory and motor skills. If it works in humans, it could lead to a paradigm shift in stroke treatment.
Long COVID-19 and chronic conditions after viral infections may stem from an overactive immune response
Understanding the immunological mechanisms underlying long COVID-19 is the first step to addressing a quickly worsening public health problem.
Why don't surgeons train like fighter pilots? Now some do.
Using AI and analysis, Theator is helping surgeons improve how pilots and pro athletes do: by going to the tape.
The Biden administration is preparing for legal psychedelics within two years 
The Biden administration’s Department of Health and Human Services has sent a memo supportive of psychedelic therapies. What does that mean for the field?
ADHD drugs might also treat Alzheimer’s disease
Scientists reviewed 40 years of clinical studies that assessed the effects of NA-targeting drugs, such as certain ADHD drugs, on Alzheimer’s.
A cheap nasal spray cuts COVID-19 risk by 62%
A low-cost nasal spray co-developed by Oxford researchers could be the next powerful weapon against COVID-19.
Your genes may impact psychedelic experiences 
UNC researchers have found evidence that the genetic makeup of a crucial receptor may impact your psychedelic experience.
Harvard scientists closer to solving centuries-old heart mystery
Harvard researchers have used a new method to crack the heart’s weird spiral muscle.
MIT engineers 3D-print rubbery brain implants that don’t “stab” the brain
How do you engineer an implant that doesn't harm an organ as soft as tofu? MIT engineers 3D-printed new soft brain implants.
How child mortality fell from 40% to 3.7% in 200 years 
The collapse in child mortality rates is a testament to the tremendous benefits of scientific, technological, and economic progress.
Large study of 20,000 cats and dogs could help pets live longer 
Mars Petcare has announced the opening of a massive biobank to study aging and pet diseases.